Mark von Itzstein is a Professor of Chemical Biology and Director of the Institute for Glycomics (Griffith University), which he established in 2000. He is an international leader in glycoscience, particularly in the study of host glycan–pathogen interactions, and anti-infective drug discovery. His group has contributed to the discovery of novel anti-microbial drugs, including novel anti-viral drugs and anti-cancer drugs based on carbohydrate-related pathways and the outcomes of these programs. https://www.remarkablegriffith.com.au/professor-mark-von-itzstein/